ParenteL. Deflazacort: therapeutic index, relative potency and equivalent doses versus other corticosteroids. BMC Pharmacol Toxicol. 2017:18(1):1. doi:10.1186/s40360-016-0111-8.
2.
CuadradoMJSannaG. Headache and systemic lupus erythematosus. Lupus. 2003;12(12):943-946. doi:10.1191/0961203303lu506oa.
3.
MitsikostasDDPetrosPSGoadsbyPJ. A meta-analysis for headache in systemic lupus erythematosus: the evidence and the myth. Brain. 2004;127(5):1200-1209. doi:10.1093/brain/awh146.
4.
JohnSHajj-AliRA. Headache in autoimmune diseases. Headache. 2014;54(3):572-582. doi:10.1111/head.12306.
5.
AinialaHLoukkolaJPeltolaJKorpelaMHietaharjuA. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology. 2001;57(3):496-500. doi:10.1212/wnl.57.3.496.
6.
HanlyJG. Diagnosis and management of neuropsychiatric SLE. Nat Publ Gr. 2014;10(6):338-347. doi:10.1038/nrrheum.2014.15.
7.
PruittAA. Central nervous system infections in immunocompromised patients. Curr Neurol Neurosci Rep. 2021;21(7):37. doi:10.1007/s11910-021-01119-w.
8.
RathTJHughesM. Imaging of cerebritis, encephalitis, and brain abscess. Neuroimaging Clin N Am;22(4):585-607. doi:10.1016/j.nic.2012.04.002.
9.
MarcusCFeiziPHoggJ, et al.Imaging in differentiating cerebral toxoplasmosis and primary CNS lymphoma with special focus on FDG PET/CT. Am J Roentgenol. 2021;216(1):157-164. doi:10.2214/AJR.19.22629.
10.
Panel on Opportunistic Infections in Adults in Adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: recommendations from the centers for disease control and prevention, the National institutes of health, and the HIV medicine association of the infectious diseases society of America. Available at: https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/Adult_OI.pdf. Acessed 10 July 2021.
11.
AnandP. Neurologic infections in patients on immunomodulatory and immunosuppressive therapies. Continuum (Minneap Minn). 2021;27(4):1066-1104. doi:10.1212/CON.0000000000000985.
12.
BahrNCTugumeLRajasinghamR, et al.Improved diagnostic sensitivity for tuberculous meningitis with Xpert® MTB/RIF of centrifuged CSF. Int J Tubercul Lung Dis. 2015;19(10):1209-1215. doi:10.5588/ijtld.15.0253.
13.
Rosa JúniorMAmorimACBaldonIV, et al.Paracoccidioidomycosis of the central nervous system: CT and MR imaging findings. AJNR Am J Neuroradiol. 2019;40(10):1681-1688. doi:10.3174/ajnr.A6203.
14.
BlackKEBadenLR. Fungal infections of the CNS: treatment strategies for the immunocompromised patient. CNS Drugs. 2007;21(4):293-318. doi:10.2165/00023210-200721040-00004.
15.
Sánchez-PortocarreroJPérez-CeciliaECorralORomero-VivasJPicazoJJ. The central nervous system and infection by Candida species. Diagn Microbiol Infect Dis. 2000;37(3):169-179. doi:10.1016/S0732-8893(00)00140-1.
16.
PanackalAAWilliamsonPR. Fungal infections of the central nervous system. Continuum (Minneap Minn). 2015;21(6 Neuroinfectious Disease):1662-1678. doi:10.1212/CON.0000000000000241.
